- Home
- VSTS vs PRTA Comparison
VSTS vs PRTA Comparison
Compare VSTS & PRTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VSTS
- PRTA
- Stock Information
- Founded
- VSTS 1936
- PRTA 2012
- Country
- VSTS United States
- PRTA Ireland
- Employees
- VSTS N/A
- PRTA N/A
- Industry
- VSTS
- PRTA Biotechnology: Pharmaceutical Preparations
- Sector
- VSTS
- PRTA Health Care
- Exchange
- VSTS Nasdaq
- PRTA Nasdaq
- Market Cap
- VSTS 572.2M
- PRTA 472.1M
- IPO Year
- VSTS N/A
- PRTA N/A
- Fundamental
- Price
- VSTS $5.30
- PRTA $10.27
- Analyst Decision
- VSTS Sell
- PRTA Buy
- Analyst Count
- VSTS 4
- PRTA 9
- Target Price
- VSTS $9.13
- PRTA $16.14
- AVG Volume (30 Days)
- VSTS 2.0M
- PRTA 562.3K
- Earning Date
- VSTS 11-20-2025
- PRTA 11-06-2025
- Dividend Yield
- VSTS 1.32%
- PRTA N/A
- EPS Growth
- VSTS N/A
- PRTA N/A
- EPS
- VSTS N/A
- PRTA N/A
- Revenue
- VSTS $2,707,109,000.00
- PRTA $10,341,000.00
- Revenue This Year
- VSTS N/A
- PRTA N/A
- Revenue Next Year
- VSTS $0.29
- PRTA $602.32
- P/E Ratio
- VSTS N/A
- PRTA N/A
- Revenue Growth
- VSTS N/A
- PRTA N/A
- 52 Week Low
- VSTS $3.98
- PRTA $4.32
- 52 Week High
- VSTS $17.83
- PRTA $18.78
- Technical
- Relative Strength Index (RSI)
- VSTS 59.96
- PRTA 54.22
- Support Level
- VSTS $4.83
- PRTA $10.34
- Resistance Level
- VSTS $5.30
- PRTA $11.17
- Average True Range (ATR)
- VSTS 0.22
- PRTA 0.53
- MACD
- VSTS -0.01
- PRTA -0.06
- Stochastic Oscillator
- VSTS 83.97
- PRTA 31.73
About VSTS Vestis Corporation
Vestis Corp is a provider of uniform rentals and workplace supplies across the United States and Canada. It provides uniforms, mats, towels, linens, restroom supplies, first-aid supplies, safety products, and other workplace supplies. The Company serves customers ranging from small, family-owned operations with a single location to large corporations and national franchises with multiple locations. The company operates in the United States and Canada as reportable segments. The company earns the majority of its revenue from the United States.
About PRTA Prothena Corporation plc
Prothena Corp PLC is a clinical biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating neurodegenerative and rare and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including ATTR amyloidosis [Coramitug (PRX004)], Alzheimer's disease (PRX123), Neurodegeneration (PRXPRX019), and Others.